Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab

摘要

Background: Post-transplant focal segmental glomerulosclerosis (FSGS) is associated with renal allograft loss. Currently, optimal treatment remains controversial.